Persistent factor VIII inhibitors and orthopaedic complications in children with severe haemophilia A

Haemophilia

Volumn 17, Issue 3, 2011, Pages 490-493

  Abdel Messih, I Y ^a   Mohamed Habashy, D M ^a   Moftah, S G ^a   El Alfy, M ^b  

^a Clinical Pathology ^*  (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Arthropathy; Factor VIII inhibitors; Haemophilia A; Osteopenia

Indexed keywords

BLOOD CLOTTING FACTOR 8 INHIBITOR;

ADOLESCENT; ARTICLE; BONE DENSITY; CHILD; CLINICAL ARTICLE; DUAL ENERGY X RAY ABSORPTIOMETRY; FOLLOW UP; HEMOPHILIA A; HEPATITIS C; HUMAN; KNEE DISEASE; LUMBAR SPINE; OSTEOPENIA; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; BLOOD COAGULATION FACTOR INHIBITORS; BONE DENSITY; BONE DISEASES, METABOLIC; CHILD; CHILD, PRESCHOOL; FACTOR VIII; HEMOPHILIA A; HUMANS; JOINT DISEASES; KNEE JOINT; LUMBAR VERTEBRAE;

EID: 79955160940     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02447.x     Document Type: Article

References (23)

1. Morfini M, Haya S, Tagariello G et al. European study on orthopaedic status of haemophilia patients with inhibitors. Haemophilia 2007; 13: 606-12.
2. El Alfy MS, Tantawy AA, Ahmed MH, Abdin IA. Frequency of inhibitor development in severe haemophilia A children treated with cryoprecipitate and low-dose immune tolerance induction. Haemophilia 2000; 6(Suppl. 6): 635-8.
3. Ghosh K, Shetty S. Immune response to FVIII in hemophilia A: an overview of risk factors. Clin Rev Allergy Immunol 2009; 37: 58-66.
4. Donfield SM, Lynn HS, Lail AE, Hoots WK, Berntorp E, Gomperts ED. Delays in maturation among adolescents with hemophilia and a history of inhibitors. Blood 2007; 110: 3656-61.
5. Jamil A, Bayoumy M, Iram D, Adler B. Pediatric severe hemophilia: initial presentation, characteristics & complications. Int J Hematol 2004; 1: 1540-2649.
6. Mahajan A, Verma S, Singh JB et al. Hemophilic arthropathy. JK Sci 2005; 7(Suppl. 4): 228-30.
7. Katsarou O, Terpos E, Chatzismalis P et al. Increased bone resorption is implicated in the pathogenesis of bone loss in hemophilics: correlation with hemophilic arthropathy and HIV infection. Ann Hematol 2009; 89: 67-74.
8. Barnes C, Wong P, Egan B et al. Reduced bone density among children with severe hemophilia. Pediatrics 2004; 114: 177-81.
9. Wallny TA, Scholz DT, Oldenburg J et al. Osteoporosis in haemophilia - an underestimated comorbidity? Haemophilia 2007; 13(Suppl. 1): 79-84.
10. Tsoukas C, Eyster ME, Shingo S et al. Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy. Blood 2006; 107: 1785-90.
11. White GC II, Rosendaal F, Aledort LM, Lusher JM, Rotschild C, Ingerslev J. Definitions in haemophilia [abstract]. Thromb Haemost 2001; 85: 560-75.
12. Luck JV, Silva M, Rodriguez-Merchan EC, Ghalambor N, Zahiri CA, Finn RS. Hemophilic arthropathy. J Am Acad Orthop Surg 2004; 12: 234-45.
13. Ng WH, Chu WCW, Shing MK et al. Role of imaging in management of hemophilic patients. Am J Roentgenol 2005; 184: 1619-23.
14. Mora S, Boechat MI, Pietka E, Huang HK, Gilsanz V. Skeletal age determination in children of European & African descent. Pediatr Res 2001; 50(Suppl. 5): 624-8.
15. Kalkwarf HJ, Zemel BS, Gilsanz V et al. The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab 2007; 92: 2087-99.
16. Doherty M, Lanyon P, Ralston SH. Musculoskeletal disorders. In: Boon NA, Colledge NR, Walker BR, Hunter JAA eds. Davidson's Principles & Practice of Medicine, 20th edition. Edinburgh, UK: Churchill Livingstone Elseviers, 2006: 1065-144.
17. Abdelrazik N, Reda M, El-Ziny M, Rabea H. Evaluation of bone mineral density in children with hemophilia. Hematology 2007; 12: 431-7.
18. Giangrande PL. Treatment of patients with haemophilia and inhibitory antibodies. Indian J Pediatr 2003; 70(Suppl. 8): 655-9.
19. Harijadi A, Gatot D, Akib AAP. The prevalence of factor VIII inhibitor in patients with severe hemophilia-A and its clinical characteristics. Paediatr Indones 2005; 45: 177-81.
20. Lacroix-Desmazes S, Wootla B, Dasgupta S et al. Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII. J Immunol 2006; 177: 1355-63.
21. Giangrande PL, Wilde JT, Madan B et al. Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors. Haemophilia 2009; 15(Suppl. 2): 501-8.
22. Mitchell J, Phillott A. Haemophilia and inhibitors 1: diagnosis and treatment. Nurs Times 2008; 104: 26-7.
23. Fischer K, Valentino L, Ljung R, Blanchette V. Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors. Haemophilia 2008; 14: 196-201.